Vaccine
Herausgeber
Elsevier Sci Ltd
International Standard Serial Number (ISSN )
0264-410X
ISSN gedruckt
0264-410X
http://www.bibliothek.uni-regensburg.de/ezeit/?1468474-
2025
Vaccination strategies to protect chickens from fowl adenovirus (FAdV)-induced diseases: A comprehensive review
2023 Aerosol delivered irradiated Escherichia coli confers serotype-independent protection and prevents colibacillosis in young chickens
2022 Experimental reproduction of histomonosis caused by Histomonas meleagridis genotype 2 in turkeys can be prevented by oral vaccination of day-old birds with a monoxenic genotype 1 vaccine candidate
2022 Vaccination with a fowl adenovirus chimeric fiber protein (crecFib-4/11) simultaneously protects chickens against hepatitis-hydropericardium syndrome (HHS) and inclusion body hepatitis (IBH)
2020 Successful reproduction of adenoviral gizzard erosion in 20-week-old SPF layer-type chickens and efficacious prophylaxis due to live vaccination with an apathogenic fowl adenovirus serotype 1 strain (CELO)
2019 Combination therapy of rabies-infected mice with inhibitors of pro-inflammatory host response, antiviral compounds and human rabies immunoglobulin.
2019 Evaluation of in vitro inhibitory potential of type-I interferons and different antiviral compounds on rabies virus replication.
2017 Vaccination against histomonosis limits pronounced changes of B cells and T-cell subsets in turkeys and chickens
2016 Assessment of safety and reproductive performance after vaccination with a modified live-virus PRRS genotype 1 vaccine in pregnant sows at various stages of gestation.
2014 Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice.
2014 Proteome-wide screening of the European porcine reproductive and respiratory syndrome virus reveals a broad range of T cell antigen reactivity.
2014 Recombinant FAdV-4 fiber-2 protein protects chickens against hepatitis-hydropericardium syndrome (HHS).
2013 In vitro attenuated Histomonas meleagridis does not revert to virulence, following serial in vivo passages in turkeys or chickens.
2013 The legal foundation of the production and use of herd-specific vaccines in Europe.
2012 Characterisation of vaccine-induced, broadly cross-reactive IFN-γ secreting T cell responses that correlate with rapid protection against classical swine fever virus.
2011 Distinctive anti-allergy properties of two probiotic bacterial strains in a mouse model of allergic poly-sensitization.
2011 Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.
2011 Protection provided by a recombinant ALVAC(®)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain.
2010 Bluetongue virus RNA detection by RT-qPCR in blood samples of sheep vaccinated with a commercially available inactivated BTV-8 vaccine.
2010 Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine.
2010 Comparison of immunogenicity and safety between two paediatric TBE vaccines.
2010 Diazepam leads to enhanced severity of orthopoxvirus infection and immune suppression.
2009 Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS.
2009 Type I interferons as mediators of immune adjuvants for T- and B cell-dependent acquired immunity.
2009 Vaccination with the Mycoplasma suis recombinant adhesion protein MSG1 elicits a strong immune response but fails to induce protection in pigs.
2008 Cloned Histomonas meleagridis passaged in vitro resulted in reduced pathogenicity and is capable of protecting turkeys from histomonosis.
2008 Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2.
2008 The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex.
2007 Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2).
2007 Use of a genetic cholera toxin B subunit/allergen fusion molecule as mucosal delivery system with immunosuppressive activity against Th2 immune responses.
2006 Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus.
2005 Comparative immunogenicity of the hepatitis B virus core 149 antigen displayed on the inner and outer membrane of bacterial ghosts.
2005 Mucosal targeting of allergen-loaded microspheres by Aleuria aurantia lectin.
2001 Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares.
2000 Use of apathogenic vaccinia virus MVA expressing EHV-1 gC as basis of a combined recombinant MVA/DNA vaccination scheme.
-
Schwarz, Lukas
2020 -
Hammer, Sabina
2018 -
Saleh, Mona
2018 -
Fereidouni, Sasan
2016 -
Jensen-Jarolim, Erika
2012 -
Spergser, Joachim
2012 -
Joachim, Anja
2009 -
Möstl, Karin
2005 -
Saalmüller, Armin
2004
-
2025
Vaccination strategies to protect chickens from fowl adenovirus (FAdV)-induced diseases: A comprehensive review
2023 Aerosol delivered irradiated Escherichia coli confers serotype-independent protection and prevents colibacillosis in young chickens
2022 Experimental reproduction of histomonosis caused by Histomonas meleagridis genotype 2 in turkeys can be prevented by oral vaccination of day-old birds with a monoxenic genotype 1 vaccine candidate
2022 Vaccination with a fowl adenovirus chimeric fiber protein (crecFib-4/11) simultaneously protects chickens against hepatitis-hydropericardium syndrome (HHS) and inclusion body hepatitis (IBH)
2020 Successful reproduction of adenoviral gizzard erosion in 20-week-old SPF layer-type chickens and efficacious prophylaxis due to live vaccination with an apathogenic fowl adenovirus serotype 1 strain (CELO)
2019 Combination therapy of rabies-infected mice with inhibitors of pro-inflammatory host response, antiviral compounds and human rabies immunoglobulin.
2019 Evaluation of in vitro inhibitory potential of type-I interferons and different antiviral compounds on rabies virus replication.
2017 Vaccination against histomonosis limits pronounced changes of B cells and T-cell subsets in turkeys and chickens
2016 Assessment of safety and reproductive performance after vaccination with a modified live-virus PRRS genotype 1 vaccine in pregnant sows at various stages of gestation.
2014 Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice.
2014 Proteome-wide screening of the European porcine reproductive and respiratory syndrome virus reveals a broad range of T cell antigen reactivity.
2014 Recombinant FAdV-4 fiber-2 protein protects chickens against hepatitis-hydropericardium syndrome (HHS).
2013 In vitro attenuated Histomonas meleagridis does not revert to virulence, following serial in vivo passages in turkeys or chickens.
2013 The legal foundation of the production and use of herd-specific vaccines in Europe.
2012 Characterisation of vaccine-induced, broadly cross-reactive IFN-γ secreting T cell responses that correlate with rapid protection against classical swine fever virus.
2011 Distinctive anti-allergy properties of two probiotic bacterial strains in a mouse model of allergic poly-sensitization.
2011 Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.
2011 Protection provided by a recombinant ALVAC(®)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain.
2010 Bluetongue virus RNA detection by RT-qPCR in blood samples of sheep vaccinated with a commercially available inactivated BTV-8 vaccine.
2010 Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine.
2010 Comparison of immunogenicity and safety between two paediatric TBE vaccines.
2010 Diazepam leads to enhanced severity of orthopoxvirus infection and immune suppression.
2009 Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS.
2009 Type I interferons as mediators of immune adjuvants for T- and B cell-dependent acquired immunity.
2009 Vaccination with the Mycoplasma suis recombinant adhesion protein MSG1 elicits a strong immune response but fails to induce protection in pigs.
2008 Cloned Histomonas meleagridis passaged in vitro resulted in reduced pathogenicity and is capable of protecting turkeys from histomonosis.
2008 Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2.
2008 The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex.
2007 Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2).
2007 Use of a genetic cholera toxin B subunit/allergen fusion molecule as mucosal delivery system with immunosuppressive activity against Th2 immune responses.
2006 Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus.
2005 Comparative immunogenicity of the hepatitis B virus core 149 antigen displayed on the inner and outer membrane of bacterial ghosts.
2005 Mucosal targeting of allergen-loaded microspheres by Aleuria aurantia lectin.
2001 Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares.
2000 Use of apathogenic vaccinia virus MVA expressing EHV-1 gC as basis of a combined recombinant MVA/DNA vaccination scheme.
-
Schwarz, Lukas
2020 -
Hammer, Sabina
2018 -
Saleh, Mona
2018 -
Fereidouni, Sasan
2016 -
Jensen-Jarolim, Erika
2012 -
Spergser, Joachim
2012 -
Joachim, Anja
2009 -
Möstl, Karin
2005 -
Saalmüller, Armin
2004